Bendazac

CAS : 20187-55-7

Ref. TR-B132600

Informations sur le produit

• Nom: Bendazac
• Synonymes: [[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic Acid, 1-Benzylindazole-3-oxyacetic Acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic Acid, AF 983, Bendazolic Acid, Bindazac, Dogalina, Zildasac, Zildazac, (1-Benzyl-1H-indazol-3-yloxy)-acetic acid, (1-Benzyl-3-indazolyl)oxyacetic acid, 1-Benzylindazole-3-oxyacetic acid, 2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid, 2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid, 2-(1-Benzylindazol-3-yl)oxyacetic acid, 2-[[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic acid, 20187-55-7, Acetic acid, [(1-benzyl-1H-indazol-3-yl)oxy]-, Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, Af 983, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid, acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-

Description

Applications Bendazac is a non-steroidal anti-inflammatory drug (NSAID). Bendazac is often used for joint and muscular pain. Bendazac has potential as an anti-denaturant drug for cataract and other condensation diseases as it protects proteins from denaturation induced by different agents.
References Silvestrini, B. et al.: Arzneim.-Forsch., 19, 30 (1969); Saso, L. et al.: Med. Hypoth., 56, 114 (2001); Saso, L. et al.: Arch. Pharm. Res., 24, 150 (2001);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 282.29
• Formule: C₁₆H₁₄N₂O₃
• Couleur/Forme: Neat
• InChI: InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• Code InChI: InChIKey=BYFMCKSPFYVMOU-UHFFFAOYSA-N
• SMILES: O=C(O)COc1nn(Cc2ccccc2)c2ccccc12